Functional Resolution Of PTEX, The Exporter Of Virulence Factors In Malaria Parasites.
Funder
National Health and Medical Research Council
Funding Amount
$625,212.00
Summary
Almost half a million people die each year of malaria and nearly half the world’s population are at risk. To eliminate malaria this century we will need new drugs and vaccine to fight the disease. One potential drug target are the molecular gateways called PTEX, that are used by parasites to export virulence proteins into their human host cells. This grant aims to understand how the PTEX molecular machines work so we can develop new drugs to block them and kill the parasites.
Disease Burden, Risk Factors And Treatment Of Knowlesi Malaria
Funder
National Health and Medical Research Council
Funding Amount
$95,564.00
Summary
Plasmodium knowlesi is a form of monkey malaria recently found to also cause increasing numbers of natural infections in humans in South-East Asia. This research will describe the burden of P. knowlesi malaria in an area of Malaysian Borneo. The risk factors for acquiring P. knowlesi malaria will be assessed. Finally the optimal treatment for non-severe cases of P. knowlesi and P. vivax malaria will also be evaluated by comparing the 2 currently recommended anti-malarial medications in Malaysia.
Development Of Novel Anti-malaria Drugs That Block Parasite Invasion
Funder
National Health and Medical Research Council
Funding Amount
$1,035,623.00
Summary
Malaria is a devastating parasitic disease that kills over 400,000 people a year. Antimalarial drugs play a crucial role in helping eradicate malaria but of great concern is that parasites are becoming resistant to current drugs. We are developing drugs that prevent parasites from invading and proliferating in human blood which causes malaria. We are also discovering how the drugs work with the aim of greatly improving their performance towards clinical uptake.
Malaria In Pregnancy: Exposure, Immunity And Complications
Funder
National Health and Medical Research Council
Funding Amount
$549,723.00
Summary
Increasing malaria control efforts may lead to lack of exposure needed to develop immunity. We will use plasma samples from Africa, PNG and Asia, and measures of immunity we have developed, to discover (1) which are the most important protective immune responses and (2) how are these affected by changing exposure or new drugs. Overall, we hope to identify markers of protective immunity that can be used to identify women at most risk of malaria in pregnancy and its complications
Griseofulvin, A Novel Host-directed Antimalarial Drug
Funder
National Health and Medical Research Council
Funding Amount
$461,551.00
Summary
This grant is for a Phase II clinical trial to test an FDA & TGA approved drug for a new use as an antimalarial drug. The parasite uses an enzyme from the human RBC to help it replicate & early trials show this drug appears to disrupt the life cycle of the parasite. This Phase II clinical trial will test the drug on human subjects, & if successful, the drug will be a new and novel way in which to treat and prevent malarial infections in humans.
Over the next 5 years my team and I plan to study parasite invasion and blood cell enslavement to guide the design of better vaccines and medicines. Malaria as a deadly parasitic disease caused by large-scale infection of the body’s red blood cells. To design more effective vaccines and improved drugs to globally eliminate malaria we need to improve our understanding of how parasites infect and enslave our blood cells so they can grow rapidly and avoid our immune system.
The major objective of this research is to advance the development of highly effective malaria vaccines through i) defining mechanisms and targets of human immunity to malaria to establish a rational basis for vaccine design; ii) advancing the development of lead candidates and promising new candidates and combinations; iii) advancing vaccine platforms that induce potent protective immune responses; iv) develop and validate urgently-needed immunological assays for vaccine development and testing
Spatial Analysis Of The An. Punctulatus Group Of Malaria Vectors In Australia And Papua New Guinea.
Funder
National Health and Medical Research Council
Funding Amount
$66,430.00
Summary
Malaria has been eradicated from Australia but the country remains receptive to its reintroduction as the mosquitoes which transmit the disease are still present in the tropical north of the country. These are the Anopheles punctulatus group which are the major malaria vectors in the south west Pacific region. The Australian Army Malaria Institute conducted Operation Anopheles to collect these mosquitoes in northern Australia and Papua New Guinea by detailed surveys with the aid of helicopters a ....Malaria has been eradicated from Australia but the country remains receptive to its reintroduction as the mosquitoes which transmit the disease are still present in the tropical north of the country. These are the Anopheles punctulatus group which are the major malaria vectors in the south west Pacific region. The Australian Army Malaria Institute conducted Operation Anopheles to collect these mosquitoes in northern Australia and Papua New Guinea by detailed surveys with the aid of helicopters and 4-wheel-drive vehicles. These surveys, which were made for a month each year between 1984-1998, represent the most detailed dataset of mosquito locality records that have ever been produced. This project will utilise the computing power of modern Geographical Information Systems (GIS) software and computer induction techniques to spatially map the range of the different mosquitoes collected during Operation Anopheles to highlight environmental characteristics which limit their distribution and to permit control activities to accurately target the species which actually transmit malaria.Read moreRead less
Population Genomics Of Plasmodium Vivax In Papua New Guinea
Funder
National Health and Medical Research Council
Funding Amount
$597,238.00
Summary
Plasmodium vivax malaria is a serious global public health problem that has not received the attention it deserves, despite having serious clinical implications and presenting a major problem for regional malaria control programmes. In a study of people living in a malarious area of PNG, we aim to investigate the diversity of natural parasite populations, to better understand the possible effects of malaria control interventions on transmission and human immunity.
The Molecular Epidemiology Of Malaria Transmission In The Solomon Islands
Funder
National Health and Medical Research Council
Funding Amount
$69,098.00
Summary
The recent dramatic reduction in malaria burden has prompted a shift from control to elimination and aims to interrupt malaria transmission itself. Achieving this requires the development of set tools that directly target transmission. Little is known about the epidemiology of malaria transmission in the SW Pacific. The goal of this PhD project is to determine the dynamics of malaria transmission in Solomon Islands using a combination of large epidemiological studies and novel molecular assays.